{"id":"W4282047752","doi":"10.1200/jco.2022.40.16_suppl.e14044","title":"Efficacy of Gemcitabine in recurrent meningioma: A phase II study.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Terry Fox Research Institute","keywords":"Medicine; Gemcitabine; Common Terminology Criteria for Adverse Events; Adverse effect; Progression-free survival; Internal medicine; Phases of clinical research; Chemotherapy; Oncology; Radiation therapy; Surgery","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002222249,0.001313993,0.002818432,0.0005065386,0.0004226565,0.0008098551,0.0009797026,0.001384294,0.002950493],"category_scores_gemma":[0.000845005,0.000499169,0.001247336,0.0005068659,0.0005941339,0.0005478246,0.0004044618,0.002102579,0.0008771794],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007304627,"about_ca_system_score_gemma":0.001440363,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006592366,"about_ca_topic_score_gemma":0.001490561,"domain_scores_codex":[0.9994943,0.000253302,0.00004430933,0.0000690989,0.00006217107,0.00007676304],"domain_scores_gemma":[0.9993532,0.0001045022,0.0001491948,0.00006113503,0.00004244323,0.0002895239],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5475803,0.1257112,0.01505533,0.003119604,0.003032976,0.002079841,0.0005477649,0.002817513,0.0730098,0.0003470471,0.006134666,0.220564],"study_design_scores_gemma":[0.3399339,0.6281471,0.01900834,0.0001026878,0.0008860083,0.001418649,0.00006511495,0.001096776,0.004598092,0.0001557068,0.004553844,0.00003384149],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984919,0.008340038,0.0007325513,0.0003628502,0.0001230659,0.003212862,0.0008650778,0.00008605866,0.001358572],"genre_scores_gemma":[0.9760849,0.008729776,0.003070341,0.001544404,0.0003508025,0.004492206,0.003055001,0.00004798173,0.002624597],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002950493,"threshold_uncertainty_score":0.01175255,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1885548469309659,"score_gpt":0.5161420882940101,"score_spread":0.3275872413630442,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}